Quantcast
Last updated on April 23, 2014 at 17:22 EDT

Latest Hepatocellular carcinoma Stories

2014-01-27 12:29:29

SAN DIEGO, Jan. 27, 2014 /PRNewswire/ -- Polaris Group announced today that ADI-PEG 20, arginine deiminase formulated with polyethylene glycol, acts as a radiosensitizer of pancreatic cancer both in tissue culture and in mice with human pancreatic cancer. These results were presented at the American Society of Clinical Oncology's Gastrointestinal Cancers Symposium in San Francisco, California. The study was performed in conjunction with collaborators at MD Anderson Cancer Center in...

2014-01-27 08:27:50

Latest Data from Large Subgroup of Patients Shows that the Combination of ThermoDox® and Optimized RFA Provides a Statistically Significant Survival Improvement of Over 50% LAWRENCEVILLE, N.J., Jan. 27, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) today announced that the latest overall survival data from its post-hoc analysis of results from the Company's Phase III HEAT Study of ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin in...

2014-01-16 10:01:37

Study shows safe and simpler treatment for potentially deadly, liver-damaging disease Efforts to cure hepatitis C, the liver-damaging infectious disease that has for years killed more Americans than HIV/AIDS, are about to get simpler and more effective, according to new research at Johns Hopkins and elsewhere. In a study to be reported in the Jan. 16 issue of the New England Journal of Medicine, researchers say combination treatments involving a pair of experimental, oral antiviral...

2014-01-15 08:28:43

WOONSOCKET, R.I., Jan. 15, 2014 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) has filed a U.S. provisional patent application concerning composition of matter, biological targets, mechanism of action, methods and formulations to achieve targeted tumor cell death. This patent application describes a novel class of very small noncoding double stranded RNA molecules (VSRNAs) which interfere with the basic homeostatic cellular processes in tumor cells....

2014-01-15 08:28:09

Embolization Particle and Peripheral Vascular Plug Markets will See Considerable Competitive Activity, According to Millennium Research Group TORONTO, Jan. 15, 2014 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the United States and European transcatheter embolization and occlusion (TEO) device markets will expand moderately through 2022, with embolization particles representing one of the fastest-growing...

2013-12-18 23:01:33

Technique Allows for Non-Invasive Liver Analysis and Improved Patient Outcomes East Providence, RI (PRWEB) December 18, 2013 Rhode Island Medical Imaging (RIMI) has expanded its wide-range of diagnostic services to now include liver elastography. This non-invasive procedure has proven successful for assessing liver fibrosis and cirrhosis, with virtually no patient risk. RIMI is currently the only out-patient imaging center to offer liver elastography, and it is not yet available at local...

2013-12-16 08:26:08

Penetration into Tier 2 and Tier 3 Cities of China May Increase Uptake of Targeted Therapies for HCC and Drive Market Growth, According to a New Report from Decision Resources BURLINGTON, Mass., Dec. 16, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in China, the uptake of premium-priced targeted therapies for hepatocellular carcinoma (HCC) is heavily influenced by their high cost...

2013-12-13 16:24:24

PALO ALTO, Calif., Dec. 13, 2013 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma (HCC), the most common type of liver cancer. The...

2013-12-12 11:06:49

Researchers from Taiwan reveal that antiviral therapy for hepatitis C virus (HCV) improves kidney and cardiovascular outcomes for patients with diabetes. Results of the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that incidences of kidney disease, stroke, and heart attack were lower in patients treated with pegylated interferon and ribavirin compared to HCV patients not treated with antivirals or diabetic patients not infected...

2013-12-11 08:29:17

Study evaluates eliminating coiling by using the novel anti-reflux Surefire Infusion System in radioembolization procedures WESTMINSTER, Colo., Dec. 11, 2013 /PRNewswire/ -- Surefire Medical, Inc. today announced that it has completed enrollment in the Coiling vs. Surefire Infusion System in Y90 (COSY) clinical trial. This randomized prospective study investigates the feasibility and benefits of performing Selective Internal Radiation Therapy (SIRT), or radioembolization, without...


Latest Hepatocellular carcinoma Reference Libraries

Hepatitis B
2013-02-25 09:11:23

Image Caption: This electron micrograph reveals the presence of hepatitis-B virus HBV "Dane particles", or virions. Credit: CDC/Wikipedia Hepatitis B: What Is It? Hepatitis simply means a swelling or inflammation of the liver. The type hepatitis that a person contracts (there are 5 common forms) affects their long-term prognosis. The most common and most severe of these different types of liver infection is Hepatitis B, which is caused by the hepatitis B virus (HBV). It is typically...

45_36624a455e3cd9a4152b7670308f0ffa
2011-01-20 19:14:56

Hepatitis B virus, HBV, is a part of the Hepadnaviridae family of viruses. HBV can lead to cirrhosis and hepatocellular carcinoma and has been linked to pancreatic cancer. It is classified as a species of the Orthohepadnavirus. Similar viruses have been found worldwide in great apes and monkeys. There a few different genotypes and they all differ by at least 8% of the sequence and have distinct geographical distributions and this has been associated with anthropological history. Type A is...

0_9255b919f71eff1fd4202c1dbb1795d2
2011-01-12 15:49:29

Hepadnaviruses can cause liver infections in humans and animals. The two recognized genera are Genus Orthohepadnavirus and Genus Avihepadnavirus. It has a small genome of partially double-stranded, partially single stranded circular DNA. It is a group 7 virus that uses an RNA intermediate during replication. Most people who come into contact with the virus are able to clear the infection alone although some cannot and usually progress to fulminant hepatitis. It can cause sever liver...

More Articles (3 articles) »